Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea's Health Ministry To Unveil Steeper Price Cuts After Patent Loss; Generics Could Be The Big Loser

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Korea's Ministry of Health and Welfare confirmed that it is preparing a new pricing system to further cut prices of both innovative products and generics. The plan could deal a blow to Korea's generic-dependent pharmas by eventually eliminating price differences of generics and off-patent brands under Korea's national health insurance
Advertisement

Related Content

Korea Tries To Buffer Heavy Price Cuts With R&D Incentives, But Local And Global Pharma Up In Arms
Korea Tries To Buffer Heavy Price Cuts With R&D Incentives, But Local And Global Pharma Up In Arms
Korea Tries To Buffer Heavy Price Cuts With R&D Incentives, But Local And Global Pharma Up In Arms
Korea Tries To Buffer Heavy Price Cuts With R&D Incentives, But Local And Global Pharma Up In Arms
Korea's Fair Trade Commission Looking Into Allegations That MNCs Offered Kickbacks To Block New Generic Entrants
Korea's Fair Trade Commission Looking Into Allegations That MNCs Offered Kickbacks To Block New Generic Entrants
South Korea's Health Ministry Unveils Provisions For November's Anti-rebate Law
South Korea's Health Ministry Unveils Provisions For November's Anti-rebate Law
Advertisement
UsernamePublicRestriction

Register

SC078531

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel